Trichinopoly Krishna Sandhya, Harman Nicola, Mallucci Conor, Pizer Barry, Jenkinson Michael D, Aquilina Kristian, Bull Kim, Foss-Skiftesvik Jon, Hartley Helen, Hayden James, Kennedy Colin, Thomale Ulrich W, Wilne Sophie, Wisoff Jeffrey H, Bouaouiche Faris, Hull Liz, Robinson John, Vickers Hannah L, Gamble Carrol
Department of Neurosurgery, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
University of Liverpool, Liverpool, UK.
Trials. 2025 Aug 11;26(1):286. doi: 10.1186/s13063-025-09004-4.
Central nervous system tumours affecting the brain and spine are the most common solid tumour site in the paediatric population and the most common causes of cancer death in children and young people. They are associated with high morbidity both from the tumour and the interventions used to treat them. Postoperative morbidity reporting following surgery for paediatric brain tumours is poor. This is due to variability of outcomes measured and reported and the lack of a common language when reporting adverse outcomes. One solution is to develop a core outcome set which will stipulate the minimum postoperative outcomes that should be reported. The COMBAT (Core Postoperative Morbidity Set for Paediatric Brain Tumours) Project will develop a core set of adverse outcomes that can be applied to paediatric brain tumour patients undergoing surgery.
This protocol has been developed using the COS-STAD (Core Outcome Set-Standards for Development) recommendations and the COS-STAP (Core Outcome Set-STAndardised Protocol Items) statement. A systematic review will identify adverse outcomes reported in the literature and how they are measured. Outcomes of importance to patients and their carers will be identified from semi-structured qualitative interviews with patients and their carers from Alder Hey Children's Hospital, Liverpool, UK. Consensus on the most important harms will be sought using a two-round eDelphi survey completed by national and international participants including health professionals, researchers, patients and their carers. Results of the eDelphi survey will be assessed against a pre-defined definition of consensus and discussed at an international consensus meeting attended by participants of the eDelphi survey.
There is a clear need for a common language to harmonise measurement and reporting of morbidity following surgery for paediatric brain tumour patients. This project will define postoperative adverse outcomes that are of critical importance to key stakeholders. It will standardise surgical morbidity outcome measurement and reporting in both research studies and routine clinical practice, enabling comparison across different trials, studies and clinical services. It will lay the groundwork for future research in paediatric brain tumour surgical morbidity.
This study is registered with the COMET database as Study 1968 ( https://www.comet-initiative.org/Studies/Details/1968 ), registration date: 26/10/2021.
影响大脑和脊柱的中枢神经系统肿瘤是儿童群体中最常见的实体瘤部位,也是儿童和年轻人癌症死亡的最常见原因。它们与肿瘤本身以及用于治疗的干预措施所导致的高发病率相关。儿童脑肿瘤手术后的发病率报告情况不佳。这是由于所测量和报告的结果存在差异,以及在报告不良结果时缺乏统一的语言。一种解决方案是制定一套核心结局集,规定应报告的最低术后结局。COMBAT(儿童脑肿瘤术后核心发病率集)项目将制定一套可应用于接受手术的儿童脑肿瘤患者的不良结局核心集。
本方案是根据COS - STAD(核心结局集 - 制定标准)建议和COS - STAP(核心结局集 - 标准化方案项目)声明制定的。系统评价将确定文献中报告的不良结局及其测量方法。通过对英国利物浦阿尔德希儿童医院的患者及其护理人员进行半结构化定性访谈,确定对患者及其护理人员重要的结局。将通过两轮电子德尔菲调查寻求关于最重要危害的共识,该调查由包括卫生专业人员、研究人员、患者及其护理人员在内的国内和国际参与者完成。电子德尔菲调查的结果将根据预先定义的共识定义进行评估,并在由电子德尔菲调查参与者参加的国际共识会议上进行讨论。
显然需要一种统一的语言来协调儿童脑肿瘤患者手术后发病率的测量和报告。该项目将确定对关键利益相关者至关重要的术后不良结局。它将在研究和常规临床实践中规范手术发病率结局的测量和报告,使不同试验、研究和临床服务之间能够进行比较。它将为儿童脑肿瘤手术发病率的未来研究奠定基础。
本研究已在COMET数据库注册为研究1968(https://www.comet - initiative.org/Studies/Details/1968),注册日期:2021年10月26日。